NeoGenomics, Inc. Accumulated Other Comprehensive Income
NeoGenomics, Inc. (NEO) had Accumulated Other Comprehensive Income of $4.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-07-28
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $4.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $4.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $4.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $71.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $4.00K 10-Q · filed 2026-07-28 |
| 2026-03-31 | $4.00K 10-Q · filed 2026-04-28 |
| 2025-12-31 | $4.00K 10-Q · filed 2026-07-28 |
| 2025-09-30 | $71.00K 10-Q · filed 2025-10-28 |
| 2025-06-30 | $29.00K 10-Q · filed 2025-07-29 |
| 2025-03-31 | -$56.00K 10-Q · filed 2025-04-29 |
| 2024-12-31 | -$206.00K 10-K · filed 2026-02-17 |
| 2024-09-30 | -$643.00K 10-Q · filed 2024-11-05 |
| 2024-06-30 | -$1.02M 10-Q · filed 2024-07-30 |
| 2024-03-31 | -$1.33M 10-Q · filed 2024-04-30 |
| 2023-12-31 | -$1.67M 10-K · filed 2025-02-18 |
| 2023-09-30 | -$1.85M 10-Q · filed 2023-11-06 |
| 2023-06-30 | -$2.57M 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$2.83M 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$3.90M 10-K · filed 2024-02-20 |
| 2022-09-30 | -$5.10M 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$4.06M 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$3.01M 10-Q · filed 2022-05-09 |
| 2021-12-31 | -$638.00K 10-K · filed 2023-02-24 |
| 2021-09-30 | -$390.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$333.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | -$150.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $10.00K 10-K · filed 2022-02-25 |
| 2020-09-30 | $22.00K 10-Q · filed 2020-10-29 |
| 2020-06-30 | $43.00K 10-Q · filed 2020-07-31 |
| 2020-03-31 | -$2.66M 10-Q · filed 2020-04-29 |
| 2019-12-31 | -$1.62M 10-K · filed 2021-02-25 |
| 2019-09-30 | -$2.38M 10-Q · filed 2019-11-13 |
| 2019-06-30 | -$2.16M 10-Q · filed 2019-08-07 |
| 2019-03-31 | -$1.14M 10-Q · filed 2019-05-08 |
| 2018-12-31 | -$579.00K 10-K · filed 2020-02-28 |
| 2018-09-30 | $536.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | $257.00K 10-Q · filed 2018-08-06 |
| 2018-03-31 | $499.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $274.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |